The Tissue Culture & Biobanking Shared Resource (TCBSR) is an integral part of Georgetown Lombardi Comprehensive Cancer Center (LCCC) research activities. The Cancer Center Support Grant (CCSG) has provided funding to the TCBSR since 1993. The TCBSR provides services to support LCCC investigators with the tissue culture-related aspects of their work. It also offers services that enable biobanking of blood and other biofluid specimens obtained from subjects enrolled in various LCCC studies. The TCBSR provides services, facilities and consultation to a diverse group of investigators involved in cancer research. The tissue culture services available are as follows: 1) cell culture and cell banking; 2) conditional reprogramming of cells to establish primary epithelial cell cultures from normal and cancer tissues; 3) transforming B-cells with Epstein- Barr virus (EBV) service to facilitate cancer genetics studies; 4) maintaining the LCCC repository of established cell lines; 5) performing quality control tests for cell lines, including cell line authentication and mycoplasma testing services; 6) providing a safe and secure cryostorage facility for investigators to keep frozen stocks of their cancer cell lines; 7) testing and supplying tissue culture reagents of the highest quality that have been tested for suitability in the relevant systems, as inexpensively as possible; and 8) equipping, monitoring and stocking four separate shared tissue culture laboratories for use by LCCC investigators. The TCBSR is also responsible for biobanking blood and other biofluid specimens. These services include the processing of specimens (e.g., preparing aliquots of serum, plasma, buffy coat and peripheral blood mononuclear cells [PBMCs]), banking the specimens and disbursing as needed. Bassem R. Haddad, MD, has served as the director of the TCBSR since January 2002. The TCBSR continues to be heavily used by a large number of LCCC investigators. Of 63 users in fiscal year (FY) 2017, 45 were members from all four LCCC Programs (Breast Cancer [BC], Cancer Prevention and Control [CPC], Experimental Therapeutics [ET], and Molecular Oncology [MO]), and 29 of these had peer- reviewed grants. In addition, the TCBSR provides laboratory support to six other Shared Resources.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-27
Application #
9924521
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
27
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Kim, Sang-Soo; Rait, Antonina; Garrido-Sanabria, Emilio R et al. (2018) Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation. Mol Ther 26:84-94
Taylor, Teletia R; Dash, Chiranjeev; Sheppard, Vanessa et al. (2018) The effect of a randomized controlled physical activity trial on health related quality of life in metabolically unhealthy African-American women: FIERCE STUDY. Contemp Clin Trials 67:121-128
O'Neill, Suzanne C; Evans, Chalanda; Hamilton, Rebekah J et al. (2018) Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population. Fam Cancer 17:351-360
Wallington, Sherrie Flynt; Oppong, Bridget; Iddirisu, Marquita et al. (2018) Developing a Mass Media Campaign to Promote Mammography Awareness in African American Women in the Nation's Capital. J Community Health 43:633-638
Pannkuk, Evan L; Laiakis, Evagelia C; Garcia, Melissa et al. (2018) Nonhuman Primates with Acute Radiation Syndrome: Results from a Global Serum Metabolomics Study after 7.2 Gy Total-Body Irradiation. Radiat Res :
Ahn, Jaeil; Conkright, Brian; Boca, Simina M et al. (2018) POPSTR: Inference of Admixed Population Structure Based on Single-Nucleotide Polymorphisms and Copy Number Variations. J Comput Biol 25:417-429
Ujjani, Chaitra; Wang, Hongkun; Skarbnik, Alan et al. (2018) A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. Blood Adv 2:762-768
Chang, Joanne T; Levy, David T; Meza, Rafael (2018) Examining the Transitions Between Cigarette and Smokeless Tobacco Product Use in the United States Using the 2002-2003 and 2010-2011 Longitudinal Cohorts. Nicotine Tob Res 20:1412-1416
Naab, Tammey J; Gautam, Anita; Ricks-Santi, Luisel et al. (2018) MYC amplification in subtypes of breast cancers in African American women. BMC Cancer 18:274
Alamri, Ahmad M; Liu, Xuefeng; Blancato, Jan K et al. (2018) Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. Dis Model Mech 11:

Showing the most recent 10 out of 1120 publications